Federated Hermes, Inc. Athenex, Inc. Transaction History

Federated Hermes, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.12 - $0.21 $781 - $1,367	-6,512 Reduced 51.14%	6,221 $0
Q3 2022 Nov 14, 2022	SELL	$0.24 - $1.11 $338 - $1,563	-1,409 Reduced 9.96%	12,733 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $322 - $715	786 Added 5.88%	14,142 $6,000
Q1 2022 May 13, 2022	SELL	$0.79 - $1.59 $86,553 - $174,203	-109,562 Reduced 89.13%	13,356 $11,000
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $167,168 - $361,378	122,918 New	122,918 $167,000
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $30,854 - $57,048	-3,214 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $2,979 - $5,145	245 Added 8.25%	3,214 $39,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $19.8 $3,879 - $8,137	-411 Reduced 12.16%	2,969 $59,000
Q1 2019 May 10, 2019	SELL	$11.11 - $13.49 $3,421 - $4,154	-308 Reduced 8.35%	3,380 $41,000
Q4 2018 Feb 13, 2019	SELL	$10.24 - $15.49 $4,106 - $6,211	-401 Reduced 9.81%	3,688 $46,000
Q3 2018 Nov 13, 2018	SELL	$15.53 - $19.97 $10,436 - $13,419	-672 Reduced 14.11%	4,089 $64,000
Q2 2018 Aug 10, 2018	BUY	$15.88 - $19.5 $10,115 - $12,421	637 Added 15.45%	4,761 $89,000
Q1 2018 May 09, 2018	BUY	$13.53 - $17.47 $55,797 - $72,046	4,124 New	4,124 $70,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.